Filtrer vos résultats
- 3
- 2
- 1
- 3
- 1
- 1
- 1
- 3
- 3
- 2
- 1
- 1
- 1
- 3
- 3
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
triés par
|
Effectiveness of second-line treatment in AL amyloidosis patient's refractory to M-Dex.Amyloid: The Journal of Protein Folding Disorders, 2011, 18 Suppl 1, pp.145-7. ⟨10.3109/13506129.2011.574354054⟩
Article dans une revue
hal-00945683v1
|
|||
|
Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial.Leukemia, 2013, 27 (10), pp.2102-5. ⟨10.1038/leu.2013.110⟩
Article dans une revue
hal-00945398v1
|
||
Autologus stern celle transplantation (ASCT) versus oral melphalan and high-dose dexamethasone in patients with AL (primary) amyloisdosis : results of the French multicentric randomized trial (MAG and IFM intergroup).Communication orale présentée à 'The American Society of Hematology 47th Annual meeting and Exposition", Dec 2005, Nouvelle Orléans (Louisiane), United States
Communication dans un congrès
hal-01135622v1
|